CAS 219311-43-0

N-[6-Chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide hydrochloride

Description:

N-[6-Chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide hydrochloride is a chemical compound characterized by its complex structure, which includes a sulfonamide group, a chloro-substituted aromatic ring, and an imidazole moiety. This compound is typically a white to off-white solid and is soluble in polar solvents such as water and methanol, which is common for many sulfonamide derivatives. The presence of the methanesulfonamide group contributes to its potential biological activity, often related to antibacterial or antitumor properties. The hydrochloride form indicates that it is a salt, which can enhance its stability and solubility in aqueous solutions. The compound's molecular structure suggests it may interact with biological targets through hydrogen bonding and hydrophobic interactions, making it of interest in medicinal chemistry. As with many pharmaceuticals, its safety and efficacy would be evaluated through rigorous testing in preclinical and clinical studies.

Formula: C₁₂H₁₇Cl₂N₃O₃S

InChI: InChI=1/C12H16ClN3O3S.ClH/c1-8-10(19-7-11-14-5-6-15-11)4-3-9(13)12(8)16-20(2,17)18;/h3-4,16H,5-7H2,1-2H3,(H,14,15);1H

Synonyms:

• Ro-115-1240
• Dabuzalgron hydrochloride
• R-450
• N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide hydrochloride (1:1)
• RO-1151240

Dabuzalgron HCl

CAS: 219311-43-0

Dabuzalgron, an adrenoceptor agonist, is used potentially for the treatment of urinary incontinence.

Formula: C₁₂H₁₇Cl₂N₃O₃S

Purity: 98%

Color and Shape: Solid

Molecular weight: 354.25

Ref: TM-T10952L